BNET Industries
Beckman Coulter Inc. (BEC) is in the Health Care Industry
- Revenue
- Dec 31 2007
- $2.7B
- Profit
- Dec 31 2007
- $211.3M
- Market Cap
- Sep 05 2008
- $4.4B
Latest News and Analysis
Beckman Coulter Inc. Q2 2008 Earnings Call Transcript
Beckman Coulter Inc. BEC Q2 2008 Earnings Call
Research and Markets: Beckman Coulter, Inc. Medical Equipment Market Share Analysis out Now
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c93925) has announced the addition of "Beckman Coulter, Inc. Medical Equipment Market Share Analysis" to their offering.
Beckman Coulter Inc. Q1 2008 Earnings Call Transcript
Beckman Coulter Inc. Q1 2008 Earnings Call Transcript
Research and Markets: New Beckman Coulter, Inc. Medical Equipment Market Share Report Now Available
Dublin -- Research and Markets (http://www.researchandmarkets.com/reports/c89094) has announced the addition of "Beckman Coulter, Inc. Medical Equipment Market Share Report" to their offering.
Beckman Coulter Q4 2007 Earnings Call Transcript
Beckman Coulter Q4 2007 Earnings Call Transcript
Beckman Coulter, Inc. Q3 2007 Earnings Call Transcript
Beckman Coulter, Inc. Q3 2007 Earnings Call Transcript
Inverness Medical wins three-month bidding war for Biosite.(PUBLIC COMPANIES)
If some analysts surmised that the initial offering price for Biosite Inc. was high, they must be perplexed by the bidding war that ensued between two other medical device manufacturers, Beckman Coulter Inc. and eventual winner Inverness Medical Inno If some analysts surmised that the initial...
Beckman matches Biosite bid.(PUBLIC COMPANIES)(Beckman Coulter Inc.)(Brief article)
In an unusual bidding war for a local company that began in March for local medical device maker Biosite Inc., Beckman Coulter Inc. of Fullerton increased its per share price by $5 to $90 on May 2, hours before a deadline on its original deal was to...
Beckman Coulter Inc. to Acquire Biosite Inc. for 5.02 Times Revenue
The Deal; Beckman Coulter Inc. has entered into a definitive agreement to purchase Biosite Inc. The transaction is structured as a cash tender offer of $85 per share. The offer price, which values Biosite at about $1.55 billion, represents a premium of 54 percent over Biosite's share price prior to...
Beckman Coulter Inc.(MEDICAL EQUIPMENT)
Beckman Coulter Inc. recently announced that it will move its Palo Alto, Calif., operations to Indianapolis, Ind., by the end of 2008, a move that will create more than 200 life sciences-related jobs. The company, a manufacturer of biomedical testing Beckman Coulter Inc. recently announced that...
Week In Review; From www.crainsdetroit.com, week of Sept. 30 - Oct. 6.(Beckman Coulter Inc. acquired Lumigen Inc)(General Motors Corp.,Regie Nationale des Usines Renault and Nissan Motor Company Ltd.'s negoatiations)(Omnicare Inc. and its subsidiary accus
WSU spinoff bought for $185M by California firm Wayne State University's first spinoff, Southfield-based Lumigen Inc., has been bought by Fullerton, Calif.-based medical-device maker Beckman Coulter Inc. for $185 million cash, the companies said. WSU spinoff bought for $185M by California firm...
Beckman's Right to Transfer Its HPV Business to Ventana Is Upheld
Ventana Medical Systems, Inc. (NASDAQ: VMSI) today commented on the July 27, 2006 ruling in an arbitration between Beckman Coulter, Inc. and Digene Corporation. In that decision, an International Center for Dispute Resolution arbitration panel ruled that Beckman had the right to assign its HPV business and intellectual property to...
Life science.(Beckman Coulter Inc. launches iImage cytometers)(Brief Article)
Beckman Coulter released the fully automated Cell Lab IC 100 Image Cytometer. Used to analyze cell populations in such applications as protein expression and toxicology, it enables the user to study cellular events spatially and temporally. IC 100 so Beckman Coulter released the fully automated Cell...
Laboratory equipment.(Pittcon 2005 new products: the first installation)(product launch by Beckman Coulter Inc. and Pall Corp.)(Brief Article)
Pittcon was full of displays of new lab equipment. IBO has chosen to highlight new products that represent the most interesting developments in the marketplace. Pittcon was full of displays of new lab equipment. IBO has chosen to highlight new products that represent the...
Life Science.(Pittcon 2005 new products: the first installation)(product launch by Beckman Coulter Inc., CEM Corp. and Q-Sense AB)(Brief Article)
Pittcon's "Life Science Neighborhood" seemed smaller than last year. Nonetheless, instrument companies are beginning to showcase more of their new life science offerings at Pittcon. However, Pittcon still has a way to go before it truly ref Pittcon's "Life Science Neighborhood" seemed smaller than last...
Forum Alert: Beckman Coulter, Inc. Presentation at Informed Investors Biotechnology & Healthcare Stocks Forum at the Crowne Plaza in Foster City on Dec. 7, 2004, 1:30 pm PT
FULLERTON, Calif. -- Beckman Coulter, Inc. (NYSE: BEC) will present at the following forum:
AACC Award for Outstanding Contributions through Service to the Profession of Clinical Chemistry, Sponsored by Beckman Coulter, Inc.
Karen L. Nickel, PhD, has been actively involved as a clinical chemist since 1972. Her early interest in clinical endocrinology and healthcare required her to obtain the education and credentials necessary to participate in this exciting field. She earnedKaren L. Nickel, PhD, has been actively involved as a clinical chemist...
Beckman Coulter acquires cell imaging technologies.(Executive Briefing)(Beckman Coulter Inc. acquires assets of Q3DM)(Brief Article)
Fullerton, CA 12/11/03 -- Beckman Coulter has acquired the assets of Q3DM for a combination of cash and royalties on instrument sales. The acquired assets include Q3DM's cell imaging platform, software and cell imaging applications for pharmaceutical Fullerton, CA 12/11/03 -- Beckman Coulter has acquired the...
Somalogic entered the first phase of a development agreement with Beckman Coulter.(Microarrays: company announcements)(Beckman Coulter Inc.)(SomaLogic Inc.)
* SomaLogic entered the first phase of a development agreement with Beckman Coulter trader which it will conduct a feasibility study aimed at ... * SomaLogic entered the first phase of a development agreement with Beckman Coulter trader which it will conduct a feasibility study aimed...
Beckman Coulter, Inc. Announces Conference Call To Discuss Fourth Quarter and Year-Ended 2002 Results on Monday, January 27, 2003
Business Editors
- Next »
- page 1 of 2
- « Previous
Sort byClose
View by Content TypeClose
- Incorporated: 1988
- CEO: Mr. Scott Garrett
Beckman Coulter is a biomedical testing company engaged in the manufacture of biomedical testing instrument systems, tests and supplies. Co. provides laboratory tools used to conduct basic research into the fundamental processes of human biology, to develop vaccines and drugs to treat disease, to conduct clinical trials and related research activities, and to perform various tasks from patient blood tests to diagnostic testing. Co. has four product areas, which include Chemistry Systems, Immunoassay Systems, Cellular Systems, and Discovery and Automation Systems. At Dec 31 2007, Co. marketed its products in more than 130 countries.
Key Competitors
Beckman Coulter Inc. Company Info
Board of Directors
Ms. Betty Woods
Chairwoman
Mr. Charles A. Haggerty
Dr. William N. Kelley
Mr. Scott Garrett
Mr. Kevin M. Farr
Mr. Van B. Honeycutt
Mr. James V. Mazzo
Dr. Peter B. Dervan Ph.D.
Ms. Susan R. Nowakowski
Mr. Glenn S. Schafer
Mr. Robert G. Funari
Contact Information
4300 N. Harbor Boulevard
P.O. Box 3100
Fullerton, CA
714 871-4848
NAICS Code
Analytical Laboratory Instrument Manufacturing: 334516
